Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Finasteride alone increases suicide risk, but combining it with other treatments reduces this risk.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Men with male pattern baldness are more likely to have benign prostatic hyperplasia.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

There is no link between hair loss and prostate enlargement.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.